The Life Cycle of Pharmaceuticals - Adding Value at Each Stage

Toronto, ON

December 02, 2013

Grant Worden will be speaking at this event in Toronto.

Tags:

Food and Drug Regulatory Intellectual Property Patents Pharmaceuticals

Meet the Speakers

W. Grant Worden

Toronto

Related Expertise

Related Insights

Expedited examination now available for COVID-19 related trademarks
Video: what does a new ruling on Canada’s equivalent to patent term extension mean for the pharmaceutical industry?
What to use vs. how to treat: Important distinction for patentability of health care inventions
Amgen in multiple proceedings before the Federal Court of Canada and the Federal Court of Appeal under the PM(NOC) Regulations concerning its patents for NEUPOGEN® (filgrastim)
FCA sends Differin pricing matter back to PMPRB

Back